This continuing medical education activity provides ophthalmologists with a comprehensive overview of Lambert-Eaton myasthenic syndrome (LEMS), a rare immune-mediated disorder affecting the neuromuscular junction that can present with ocular symptoms, such as ptosis and diplopia. Ophthalmologists play a crucial role in the early detection and referral of LEMS. Through expert faculty discussion and a detailed case study, ophthalmologists will learn to recognize potential patients with LEMS, understand appropriate diagnostic measures, such as voltage-gated calcium channel antibody testing and repetitive nerve stimulation, and evaluate clinical trial data on treatment options, including the US Food and Drug Administration approved therapy amifampridine. The desired results of this activity are for ophthalmologists to improve their ability to implement timely referrals, identify appropriate diagnostic measures, and evaluate clinical trial data on treatment for LEMS.
- Provider:MedEdicus, LLC
- Activity Link: https://courses.mededicus.com
- Start Date: 2025-02-20 06:00:00
- End Date: 2025-02-20 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Catalyst Pharmaceuticals - Amount: 84600.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Limited